IPO

mushrooms psychedelics psychedelic drugs
Manufacturing

Psychedelics manufacturer Optimi Health set to go public in US

Vancouver's Optimi Health has kicked off an IPO of 2.5 million shares and the timing couldn't be better for the manufacturer of psychedelic drugs.
Kevin Dunleavy May 7, 2026 11:48am
IPO initial public offering
Favicon Fierce Biotech

Avalyn brings in $300M from oversized IPO

Apr 30, 2026 3:18am
Lung
Favicon Fierce Biotech

Avalyn aims for $182M IPO to fund ph. 3 trials of lung drugs

Apr 24, 2026 7:08am
IPO initial public offering
Favicon Fierce Biotech

Avalyn plans IPO to fund ph. 3 trials of inhaled lung drugs

Apr 9, 2026 4:13am
liver
Favicon Fierce Biotech

BioVie plans $20M IPO for spinout developing liver disease drug

Mar 17, 2026 5:18am
IPO initial public offering markets raise financing

German generics maker Stada revives IPO plans: report

Aug 28, 2025 1:00pm